Category Archives: Lung Cancer

#WCLC2018 conclusions – NELSON study shows CT Screening for Nodule Volume Management Reduces Lung Cancer Mortality by 26 Percent in Men

During the World Congress on Lung Cancer held this year in Toronto, Canada were presented the findings of NELSON study. These demonstrate that the use of computed tomography (CT) screening among asymptomatic men at high risk for lung cancer led to a 26 percent (9-41%, 95% CI) reduction in lung cancer deaths at 10 years of study follow-up (at 86% […]

Read More

New ESMO tumour DNA scale helps match patients with cancer to optimal targeted medicines

A new scale for tumour DNA mutations which will simplify and standardise choices for targeted cancer treatment has been agreed by leading cancer specialists in Europe and North America. The scale, called ESCAT (ESMO Scale for Clinical Actionability of molecular Targets), is published this week in the Annals of Oncology. It aims to optimise patient care by making it easier to […]

Read More

LuCE at ASCO 2018 – Lung cancer highlights

Prof. Giulio Scagliotti talked about lungcancer highlights with Stefania Vallone, LuCE president and Diego Villalón, LuCE member. Topics focused on new treatment for scuamous cell carcinoma and combination of imunotherapy and chemotherapy for a large number of PDL-1 patients.

Read More

LuCE at ASCO 2018 – Lung cancer screening

LuCE members Walce Onlus & Fundacion Mas Que Ideas attended the American Society of Clinical Oncology (ASCO) Annual Meeting. They talked with MD Paolo Bironzo about the topics on immunotherapy in lung cancer presented at ASCO 2018. Check out here the interview https://t.co/vg13smrVYS

Read More